Cargando…

Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath

BACKGROUND: The objective of this study was to evaluate a newly-developed EASYPREP liquid-based cytology method in cervicovaginal specimens and compare it with SurePath. METHODS: Cervicovaginal specimens were prospectively collected from 1,000 patients with EASYPREP and SurePath. The specimens were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Youn Soo, Gong, Gyungyub, Sohn, Jin Hee, Ryu, Ki Sung, Lee, Jung Hun, Khang, Shin Kwang, Cho, Kyung-Ja, Kim, Yong-Man, Kang, Chang Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and The Korean Society for Cytopathology 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701823/ https://www.ncbi.nlm.nih.gov/pubmed/23837020 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.3.265

Ejemplares similares

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015)

Impact of SurePath(®) liquid-based preparation in cytological analysis of peritoneal washing in practice of gynecologic oncology
por: Tyagi, Ruchita, et al.
Publicado: (2017)

Tubercular granulomas in Bronchoalveolar lavage fluid in SurePath liquid-based cytology smears: An enigmatic finding
por: Badyal, Rama Kumari, et al.
Publicado: (2021)

A comparative analysis of conventional and SurePath liquid-based cervicovaginal cytology: A study of 140 cases
por: Sharma, Jyotsna, et al.
Publicado: (2016)

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
por: Chernesky, Max, et al.
Publicado: (2017)

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study
por: Rozemeijer, Kirsten, et al.
Publicado: (2017)

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
por: Rebolj, Matejka, et al.
Publicado: (2015)

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples
por: Ejegod, Ditte Møller, et al.
Publicado: (2016)

Can an inadequate cervical cytology sample in ThinPrep be converted to a satisfactory sample by processing it with a SurePath preparation?
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2017)

Diagnostic sensitivity for invasive cervical carcinoma of high risk HPV tests performed on SurePath™ liquid-based pap specimens
por: Nance, Keith V
Publicado: (2013)

Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid
por: Rabaan, Ali A., et al.
Publicado: (2018)

Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis
por: Fontaine, Daniel, et al.
Publicado: (2012)

Immunocytochemical expression of Ki-67/p16 in normal, atypical, and neoplastic cells in urine cytology using BD SurePath™ as preparation method
por: Østbye, Kirsten Margrethe, et al.
Publicado: (2019)

High-Risk Human Papillomavirus Detection via Cobas(®) 4800 and REBA HPV-ID(®) Assays
por: Liewchalermwong, Sasiprapa, et al.
Publicado: (2022)

Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests
por: Tardif, Keith D., et al.
Publicado: (2016)

Diagnostic Utility and Efficacy of Conventional Versus SurePath® Liquid-based Cytology in Head and Neck Pathology: A Study in an Indian Tertiary Care Hospital
por: Sharma, Sonam, et al.
Publicado: (2018)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

A prospective randomized noninferiority trial comparing conventional smears and SurePath(TM) liquid-based cytology in endoscopic ultrasound-guided sampling of esophageal, gastric, and duodenal lesions
por: Jun, Jae Chang, et al.
Publicado: (2023)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

The effect of the small amount of formaldehyde in the SurePath liquid when establishing protocols for immunocytochemistry
por: Bjønness-Jacobsen, Ellen Cathrine, et al.
Publicado: (2016)

Significance of HPV-58 Infection in Women Who Are HPV-Positive, Cytology-Negative and Living in a Country with a High Prevalence of HPV-58 Infection
por: Song, Joon Seon, et al.
Publicado: (2013)

Combining Endometrium Sampling Device and SurePath Preparation to Screen for Endometrial Carcinoma: A Validation Study
por: Wen, Jia, et al.
Publicado: (2015)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening
por: Aitken, Clare A, et al.
Publicado: (2019)

HPV-specific risk assessment of cervical cytological abnormalities
por: Zhong, Guanglei, et al.
Publicado: (2021)

Cervical cytological abnormalities and HPV infection in perinatally HIV–infected adolescents
por: Ananworanich, J, et al.
Publicado: (2015)

Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: The Korean HPV cohort
por: So, Kyeong A, et al.
Publicado: (2018)

A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population—PREDICTORS 4
por: Cuzick, Jack, et al.
Publicado: (2016)

Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology
por: Termrungruanglert, Wichai, et al.
Publicado: (2018)

Prevalence of “unclassified” HPV genotypes among women with abnormal cytology
por: Annunziata, Clorinda, et al.
Publicado: (2018)

Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath™ specimens with review of literature
por: Shidham, Vinod B, et al.
Publicado: (2007)

Additional collection devices used in conjunction with the SurePath Liquid-Based Pap Test broom device do not enhance diagnostic utility
por: Day, Sarah J, et al.
Publicado: (2004)

APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database
por: Khader, Samer N., et al.
Publicado: (2010)

The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
por: So, Kyeong A, et al.
Publicado: (2016)

Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology
por: Lee, Sung-Jong, et al.
Publicado: (2013)

Prevalence and determinants of HPV infection among Colombian women with normal cytology
por: Molano, M, et al.
Publicado: (2002)

HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities
por: Krashias, George, et al.
Publicado: (2017)

Shifting from cytology to HPV testing for cervical cancer screening in Canada
por: Delpero, Emily, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b2ehgti60j9u94700gu993bgqb